Pressure Bio's Q1 Revenues Rise on Instrument Sales | GenomeWeb

NEW YORK (GenomeWeb News) – Pressure BioSciences today reported that its first-quarter revenues increased to $306,762 from $132,376 year over year.

The firm said that sales of its Pressure Cycling Technology products and services were $222,142 versus $81,473 in the comparable quarter of 2008. Pressure Bio said the sales growth was driven by the installation of 10 Barocycler instruments during the quarter, compared to seven such sales in Q1 2008.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: role for epigenetic in neuronal excitability, and more.

The new Office of Research Integrity director is grappling with complaints from her staff, according to ScienceInsider.

Italian researchers link SNPs in the PDSS2 gene to coffee consumption in a new paper.

A gene-editing ban has been interpreted to include mitochondrial transfer, Technology Review reports.